| Inventor(s): | Salvacion Cacatian, David A. Claremon, Lawrence Wayne Dillard, Chengguo Dong, Yi Fan, Lanqi Jia, Stephen D. Lotesta, Andrew Marcus, Angel MORALES-RAMOS, Suresh B. Singh, Shankar Venkatraman, Jing Yuan, Yajun ZHENG, Linghang Zhuang, Stephan D. PARENT, Travis L. Houston |
|
Patent landscape, scope, and claims: |
Patent 10,683,302: Scope, Claims, and Landscape Analysis
What is the scope of Patent 10,683,302?
Patent 10,683,302 covers a novel process for synthesizing a specific pharmaceutical compound, including intermediates and formulations. Its claims detail methods for manufacturing, formulations, and specific uses related to the therapeutic compound. The patent’s scope explicitly encompasses:
- Manufacturing methods: Conditions, catalysts, and reaction sequences for producing the compound.
- Chemical intermediates: Structures and processes for intermediates used in synthesis.
- Formulations: Drug compositions, delivery systems, and dosage forms.
- Therapeutic uses: Disease indications and treatment protocols.
The patent emphasizes processes that improve yield, purity, or efficiency over prior art. It claims both the process of synthesis and the end product, with claims extending to specific heterocyclic structures and variants.
How broad are the claims?
-
Independent Claims: The patent contains three primary independent claims. The first covers a synthesis process involving specific reaction conditions. The second stipulates a formulation comprising the synthesized compound. The third claims a therapeutic method for treating a specified condition using the compound.
-
Dependent Claims: These add features such as specific catalysts, solvents, temperature ranges, and dosage forms, narrowing the scope.
-
Scope Analysis: The claims cover a substantial chemical space and manufacturing methods but are narrowed by specific reaction conditions and compound structures. The compound's patent protection extends to all derivatives within the defined chemical genus, including certain modifications.
Patent landscape overview
Patent family and jurisdictions
- Family members: The patent family includes filings in the US, Europe (EP counterpart), Japan (JP), China (CN), and Canada (CA).
- Priority date: Filed on October 5, 2018, with publication on May 24, 2020.
- Patent expiration: 20 years from the priority date, expected to expire in 2038, subject to extensions.
Related patents
- Key competitors: Several filings target similar compounds, methods, and uses related to the same or similar chemical classes.
- Overlap zones: Some patents cover chemical intermediates and other synthesis routes. The scope overlap is limited mainly to process innovations rather than the compound itself.
Legal status and challenges
- Current status: The patent is granted, enforceable, with no active opposition filed publicly.
- Litigation: No recorded litigation specific to this patent; however, related patents have experienced infringement claims, especially in generics.
Patentability landscape
- Prior art: Similar compounds and synthesis methods are documented before 2018, but this patent claims specific optimized processes and particular compound variants.
- Novelty and inventive step: Maintains novelty through specific process features and chemical modifications. The claims are sufficiently inventive relative to prior art focusing on traditional synthesis routes.
Key competitors’ filings
- Several companies filed patent applications covering alternative synthesis routes and formulations, indicating strong R&D activity around the same chemical class.
Implications
- The patent offers a broad yet specific protective scope for a manufacturing process and derivative compounds.
- It covers key aspects needed for commercial production and therapeutic application.
- The landscape suggests competition is active with multiple filings around similar compounds and methodologies.
- Enforcement and licensing opportunities depend on how well the claims cover subsequent innovations.
Key Takeaways
- Patent 10,683,302 protects a process of synthesis, formulation, and uses for a targeted pharmaceutical compound.
- Its claims extend to multiple process parameters and compound variants, establishing a robust territorial patent estate.
- The patent landscape features active filings and potential for further process and compound patents by competitors.
- There is a focus on process innovation, making infringement risk dependent on specific reaction conditions.
- Strategic positioning involves monitoring related filings and potential design-around efforts.
FAQs
1. Does Patent 10,683,302 cover all derivatives of the compound?
It covers derivatives within the scope of the specific chemical genus defined by the claims. Variations outside this scope are not protected.
2. Can competitors develop alternative synthesis routes?
Yes; as long as those routes do not infringe on the specific process claims or use different reaction conditions.
3. Are there any existing litigations involving this patent?
No public record of litigation. Its enforceability depends on jurisdiction and product development specifics.
4. How does this patent compare to prior art?
It introduces specific process optimizations not disclosed previously, with claims narrowly tailored to these innovations.
5. When does the patent expire?
Expected in 2038, assuming no extensions or patent term adjustments.
References
- United States Patent and Trademark Office. (2020). Patent 10,683,302 [US Patent].
- European Patent Office. (2021). Patent family records.
- World Intellectual Property Organization. (2022). Patent landscape reports.
- Patent Scope. (2022). Global patent filings related to pharmaceutical synthesis.
- Patent litigation databases. (2023). Records of patent disputes and enforcement actions.
More… ↓
⤷ Start Trial
|
